PDCD1 and neoplasm: Among immune cells isolated from tumor tissue that was collected 1 h after injection, ~5% of PD-1+ T cells were also positive for anti-PD-1 nanoparticles, which was three-fold higher than the baseline observed for control isotype nanoparticles (Fig. 3b).